Acyclovir Buccal mucosa and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Acyclovir Buccal mucosa and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: acyclovir
Brand name: Sitavig, Zovirax
Synonyms: Acyclovir, Acyclovir (Systemic)
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Acyclovir Buccal mucosa-Insulin degludec
- Acyclovir Buccal mucosa-Insulin Degludec (U-100) Prefilled Pens
- Acyclovir Buccal mucosa-Insulin Degludec (U-100) Vials
- Acyclovir Buccal mucosa-Insulin Degludec (U-200) Prefilled Pens
- Acyclovir Buccal mucosa-Insulin degludec and liraglutide
- Acyclovir Buccal mucosa-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Acyclovir Buccal Tablets
- Insulin aspart, recombinant Subcutaneous-Acyclovir Capsules
- Insulin aspart, recombinant Subcutaneous-Acyclovir Capsules and Tablets
- Insulin aspart, recombinant Subcutaneous-Acyclovir Cream
- Insulin aspart, recombinant Subcutaneous-Acyclovir injection
- Insulin aspart, recombinant Subcutaneous-Acyclovir IV Infusion